These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 31551498)

  • 1. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms.
    Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K
    Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified level of miR-376a is associated with Parkinson's disease.
    Baghi M; Rostamian Delavar M; Yadegari E; Peymani M; Pozo D; Hossein Nasr-Esfahani M; Ghaedi K
    J Cell Mol Med; 2020 Feb; 24(4):2622-2634. PubMed ID: 31930701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease.
    Fazeli S; Motovali-Bashi M; Peymani M; Hashemi MS; Etemadifar M; Nasr-Esfahani MH; Ghaedi K
    PLoS One; 2020; 15(11):e0240855. PubMed ID: 33171483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease.
    He S; Huang L; Shao C; Nie T; Xia L; Cui B; Lu F; Zhu L; Chen B; Yang Q
    Transl Neurodegener; 2021 Jul; 10(1):25. PubMed ID: 34315539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative Analysis of Gene Expression and Regulatory Network Interaction Data Reveals the Protein Kinase C Family of Serine/Threonine Receptors as a Significant Druggable Target for Parkinson's Disease.
    Odumpatta R; Arumugam M
    J Mol Neurosci; 2021 Mar; 71(3):466-480. PubMed ID: 32728898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
    Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
    Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomics and Proteomics Approach for the Identification of Altered Blood microRNAs and Plasma Proteins in Parkinson's Disease.
    Yadav SK; Jauhari A; Singh N; Pandey A; Sarkar S; Pandey S; Garg RK; Parmar D; Yadav S
    Cell Mol Neurobiol; 2023 Oct; 43(7):3527-3553. PubMed ID: 37219663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of blood microRNAs 103a, 30b, and 29a in L-dopa-treated patients with PD.
    Serafin A; Foco L; Zanigni S; Blankenburg H; Picard A; Zanon A; Giannini G; Pichler I; Facheris MF; Cortelli P; Pramstaller PP; Hicks AA; Domingues FS; Schwienbacher C
    Neurology; 2015 Feb; 84(7):645-53. PubMed ID: 25596505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum miR-30c-5p is a potential biomarker for multiple system atrophy.
    Vallelunga A; Iannitti T; Dati G; Capece S; Maugeri M; Tocci E; Picillo M; Volpe G; Cozzolino A; Squillante M; Cicarelli G; Barone P; Pellecchia MT
    Mol Biol Rep; 2019 Apr; 46(2):1661-1666. PubMed ID: 30810945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.
    Marques TM; Kuiperij HB; Bruinsma IB; van Rumund A; Aerts MB; Esselink RAJ; Bloem BR; Verbeek MM
    Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of blood serum microRNA 29 family in patients with Parkinson's disease.
    Bai X; Tang Y; Yu M; Wu L; Liu F; Ni J; Wang Z; Wang J; Fei J; Wang W; Huang F; Wang J
    Sci Rep; 2017 Jul; 7(1):5411. PubMed ID: 28710399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function.
    Miñones-Moyano E; Porta S; Escaramís G; Rabionet R; Iraola S; Kagerbauer B; Espinosa-Parrilla Y; Ferrer I; Estivill X; Martí E
    Hum Mol Genet; 2011 Aug; 20(15):3067-78. PubMed ID: 21558425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum miR-221 serves as a biomarker for Parkinson's disease.
    Ma W; Li Y; Wang C; Xu F; Wang M; Liu Y
    Cell Biochem Funct; 2016 Oct; 34(7):511-515. PubMed ID: 27748571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.
    Kong Y; Liang X; Liu L; Zhang D; Wan C; Gan Z; Yuan L
    PLoS One; 2015; 10(9):e0137432. PubMed ID: 26361355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothesis: Do miRNAs Targeting the Leucine-Rich Repeat Kinase 2 Gene (LRRK2) Influence Parkinson's Disease Susceptibility?
    Yılmaz ŞG; Geyik S; Neyal AM; Soko ND; Bozkurt H; Dandara C
    OMICS; 2016 Apr; 20(4):224-8. PubMed ID: 27093107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients.
    Ravanidis S; Bougea A; Papagiannakis N; Koros C; Simitsi AM; Pachi I; Breza M; Stefanis L; Doxakis E
    Ann Clin Transl Neurol; 2020 Sep; 7(9):1594-1607. PubMed ID: 32860338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global microRNA profiling of peripheral blood mononuclear cells in patients with Behçet's disease.
    Erre GL; Piga M; Carru C; Angius A; Carcangiu L; Piras M; Sotgia S; Zinellu A; Mathieu A; Passiu G; Pescatori M
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S72-9. PubMed ID: 26486198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology.
    Oliveira SR; Dionísio PA; Correia Guedes L; Gonçalves N; Coelho M; Rosa MM; Amaral JD; Ferreira JJ; Rodrigues CMP
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32585840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease.
    Ding H; Huang Z; Chen M; Wang C; Chen X; Chen J; Zhang J
    Parkinsonism Relat Disord; 2016 Jan; 22():68-73. PubMed ID: 26631952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease.
    Botta-Orfila T; Morató X; Compta Y; Lozano JJ; Falgàs N; Valldeoriola F; Pont-Sunyer C; Vilas D; Mengual L; Fernández M; Molinuevo JL; Antonell A; Martí MJ; Fernández-Santiago R; Ezquerra M
    J Neurosci Res; 2014 Aug; 92(8):1071-7. PubMed ID: 24648008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.